They showed that USP32 and FDFT1 expression was higher in tumor spheroids than in adnexal cells, and that the FDFT1 inhibitor ZA, blocking USP32, or interfering with the mevalonate pathway might inhibit the formation of tumor spheres in epithelial ovarian cancer (Fig. 6). The gene discussed is USP32; the disease is ovarian carcinoma.